Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsIV (INFUSION)Generic

BENDAMUSTINE HYDROCHLORIDE

BENDAMUSTINE HYDROCHLORIDE

Standard Dose
25MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary

Approval overview BENDAMUSTINE HYDROCHLORIDE is listed in Drugs@FDA under application 209814 (ANDA).

Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient BENDAMUSTINE HYDROCHLORIDE Form and strength POWDER;IV (INFUSION) - 25MG/VIAL Sponsor CELERITY PHARMS Submission history Latest submission status date: 2019-01-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview BENDAMUSTINE HYDROCHLORIDE is listed in Drugs@FDA under application 209814 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient BENDAMUSTINE HYDROCHLORIDE Form and strength POWDER;IV (INFUSION) - 25MG/VIAL Sponsor CELERITY PHARMS Submission history Latest submission status date: 2019-01-25 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.